More News

09 Jan 2018 Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter
09 Jan 2018 Teneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific Antibodies
09 Jan 2018 Incyte and Syros Announce Global Target Discovery and Validation Collaboration Focused on Myeloproliferative Neoplasms
09 Jan 2018 Alder BioPharmaceuticals® Enters into European Patent Settlement and Global License Agreement with Teva in the Field of Anti-CGRP-Based Therapy
08 Jan 2018 Imcyse announces a research collaboration with Pfizer Inc. in rheumatoid arthritis (RA)
08 Jan 2018 Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies
08 Jan 2018 Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance
08 Jan 2018 Novo Nordisk has proposed to acquire Ablynx for upto €30.50 per share in cash, consisting of €28.00 upfront and €2.50 in Contingent Value Rights
08 Jan 2018 Cypralis and Gilead Sciences, Inc. agree on license terms under which Cypralis will hold exclusive development and commercialisation rights to certain jointly-owned ‘cyprolides’ for acute and chronic degenerative diseases
07 Jan 2018 Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs
07 Jan 2018 Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercialization Partnership for Novel Immune-Mediated Dermatology Therapy Using SHR0302
07 Jan 2018 Rebiotix and CoreBiome Collaborate on Evaluating Microbiomes of Patients Treated with Microbiota Restoration Therapy™
07 Jan 2018 Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)
07 Jan 2018 KBP Biosciences Raises $76 Million in Series A Financing and Appoints Brian P. McVeigh as Chief Executive Officer
05 Jan 2018 Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases
05 Jan 2018 Takeda Announces Intention to Acquire TiGenix
04 Jan 2018 Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation
04 Jan 2018 CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics
04 Jan 2018 Beacon Discovery announces multi-year GPCR-focused drug discovery collaboration with Janssen Pharmaceuticals
04 Jan 2018 Servier and Treventis begin strategic research partnership in neurodegenerative diseases
04 Jan 2018 Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates
04 Jan 2018 MacroGenics Enters Research Collaboration with Roche to Develop a Novel Bispecific Molecule
03 Jan 2018 ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma
03 Jan 2018 Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS
03 Jan 2018 Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top